• Home
  • Search Results

Search Results

Young Adult (18-34)
2341 studies match your search
Open

Metastatic Triple Negative Breast Cancer Study

Are you battling triple-negative breast cancer? If your cancer has come back or spread, and you haven't started treatment yet, you might qualify for a clinical trial testing a new medication. Discover more about this opportunity to find a potentially better treatment option.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
Open

Young Adult Alcohol Use and Social Media Study

Are you a young adult who drinks and uses social media? We are holding in-person workshops in downtown Chapel Hill to gather feedback from young adults who drink and use social media. Compensation provided.

Age & Gender
  • 18 years ~ 25 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Cancer (Breast, Colorectal, Head and Neck, and 2 more)
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Open

An Automated Insulin Delivery System Study for Type 2 Diabetes

Are you currently using insulin to treat type 2 diabetes? Are your blood sugar values still not where your provider wants them to be? If you are willing to use an automated insulin delivery system, involving an insulin pump and a continuous glucose monitor, you may be eligible to participate in a research study to find out if the twiist system can improve glycemic control.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
Open

MRD assessment in a diverse population of patients with early-stage breast cancer -DCT

Have you diagnosed with lymph node positive early breast cancer, have received surgery, and have not received any systemic or radiation treatment prior to surgery? If so, you may be able to take part in this clinical trial which seeks to improve the treatment of early-stage breast cancer by examining ctDNA, a biomarker found in the blood that may indicate the presence of disease. This study aims to determine if ctDNA can help doctors personalize therapies leading to more effective treatment plans.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Detect-ME

Do you have acid reflux, GERD, or Barrett's Esophagus? Are you having standard of care endoscopies performed? You may be able to participate in a research study testing for Barrett's Esophagus and esophageal cancer. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Stomach and Esophageal)
  • Stomach, Digestion and Gut Health
Open

Leukemia Treatment Study

Have you been diagnosed with Leukemia? Do you have a functioning kidney, liver, and cardiac organ? If so, you may be able to participate in a study on a new drug called LBS-007. We want to find out if it is safe for people with Leukemia. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia)
Open

Trial of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer

Have you been diganosed with epithelial high grade ovarian, fallopian tube or primary peritoneal carcinoma? if so, you may be able to participate in this research study to evaluate if the combination of Trastuzumab Deruxtecan (T-DXd) and Bevacizumab works better than bevacizumab alone for the treatment of your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Ovarian)
  • Women's Health
Open

Alopecia Areata Study

Do you or your child have alopecia areata? Would you be interested in hearing more about a clinical study on alopecia areata? If so, you may be able to participate in a research study to find out how effective and safe the study medication ritlecitinib is in patients with alopecia areata.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Skin, Hair, and Nails
Open

Placebo controlled Phase 3 Trial of Descartes-08 in pateints with generalized Myasthenia Gravis

Most patients with generalized Myasthenia Gravis need treatments that carry substantial risk of side effects and toxicity, Descartes-08 is a cell therapy is a RNA based CAR-T that causes direct killing of target cells without serious generalized toxicities.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
Not currently enrolling

Family Associations with Connected Environments and Self-Perceptions

We are looking at how parents and adolescents in 5th or 6th grade use social media and how this use relates to body image and mental health. We are interested in this because of the high rates of social media use among adolescents, and the concerns the general public has about how use relates to mental health.

Age & Gender
  • 9 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Developmental
  • Mental and Emotional Health
  • Parents of Children
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research